- 6101. AOPE
- (UMLS (NCI) C0280286) =Therapeutic or Preventive Procedure
| - 6151. APC8015
- [Immune system cells that are collected from a patient with prostate cancer and treated in the laboratory with a molecule found on prostate cells. The treated cells are being studied for their ability to stimulate the immune system to kill prostate cancer cells. ( NCI )] (UMLS (NCI) C0879584) APC8015 Vaccine;
=Pharmacologic Substance; Immunologic Factor ;
|
- 6102. aorta
- [main trunk from which the systemic arterial system proceeds. ( CSP )] (UMLS (CSP) C0003483) =Body Part, Organ, or Organ Component
| - 6152. APC8015/Bevacizumab
- (UMLS (NCI) C1134539) =Therapeutic or Preventive Procedure
|
- 6103. aorta aneurysm
- [sac formed by the dilatation of the wall of the aorta. ( CSP )] (UMLS (CSP) C0003486) =Disease or Syndrome; Anatomical Abnormality ;
| - 6153. APEH
- [This gene plays a role in the degradation of oxidatively-damaged proteins in living cells. ( NCI )] (UMLS (NCI) C1332101) APEH Gene;
N-Acylaminoacyl-Peptide Hydrolase Gene =Gene or Genome ;
|
- 6104. aorta coarctation
- [congenital constriction of the aorta just distal to the left subclavian artery; causes upper body hypertension but few other symptoms; may present as headache or dyspnea on exertion. ( CSP )] (UMLS (CSP) C0003492) =Congenital Abnormality
| - 6154. APEX Nuclease (Apurinic/Apyrimidinic Endonuclease) 2 Gene
- [This gene plays a role in DNA recognition and repair. ( NCI )] (UMLS (NCI) C1425157) APEX2;
APEX2 Gene =Gene or Genome |
- 6105. aorta constriction
- [ ] (UMLS (CSP) C0597891) =Pathologic Function
| - 6155. APEX Nuclease (Multifunctional DNA Repair Enzyme) 1 Gene
- [This gene is involved in DNA repair processes. ( NCI )] (UMLS (NCI) C1332102) APEX1;
APEX1 Gene =Gene or Genome ;
|
- 6106. aorta disorder
- [condition in which there is a deviation from or interruption of the normal structure or function of the aorta, which is the main trunk of the systemic arteries. ( CSP )] (UMLS (CSP) C0003493) =Disease or Syndrome
| - 6156. APEX Nuclease-Like 2
- [Apurinic/apyrimidinic (AP) sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. AP sites are pre-mutagenic lesions that can prevent normal DNA replication so the cell contains systems to identify and repair such sites. Class II AP endonucleases cleave the phosphodiester backbone 5' to the AP site. Apurinic/Apyrimidinic Endonuclease 2, a protein encoded by the APEXL2 gene, has a weak class II AP endonuclease activity. Most of this protein is located in the nucleus but some is also present in mitochondria. This protein may play an important role in both nuclear and mitochondrial base excision repair (BER). (From LocusLink 27301) ( NCI )] (UMLS (NCI) C1332330) APEXL2;
Apurinic/Apyrimidinic Endonuclease 2;
Apurinic/Apyrimidinic Endonuclease-Like 2 =Amino Acid, Peptide, or Protein; Enzyme |
- 6107. aorta obstruction
- [blocking or clogging of the aorta, the main trunk of the systemic arteries. ( CSP )] (UMLS (CSP) C0596118) =Pathologic Function ;
=aorta disorder;
Arterial Obstruction =aorta coarctation;
| - 6157. Apex of the Heart
- (UMLS (NCI) C0225811) =Body Location or Region
|
- 6108. AORTA RESECTION & ANAST
- [ ] (UMLS (ICD9CM) C0190280) =Therapeutic or Preventive Procedure
| - 6158. Apex of the Lung
- (UMLS (NCI) C0225703) =Body Location or Region
|
- 6109. AORTA-ILIAC-FEMOR BYPASS
- [ ] (UMLS (ICD9CM) C0190431) =Therapeutic or Preventive Procedure
| - 6159. Apex of the Prostate
- [THe uppermost part of the prostate gland. ( NCI )] (UMLS (NCI) C0227959) =Body Part, Organ, or Organ Component
|
- 6110. AORTA-RENAL BYPASS
- [ ] (UMLS (ICD9CM) C0176680) =Therapeutic or Preventive Procedure
| - 6160. Apex of the Tongue
- (UMLS (NCI) C0226946) =Body Location or Region
|
- 6111. Aorta-subclavian-carotid bypass
- [ ] (UMLS (ICD9CM) C0176678) =Therapeutic or Preventive Procedure
| - 6161. APEXCARDIOGRAM
- [ ] (UMLS (ICD9CM) C0199612) =Diagnostic Procedure
|
- 6112. Aortic aneurysm and dissection
- (UMLS (ICD9CM) C1812607) =Disease or Syndrome
| - 6162. Apha-((ethylamino)methyl)-3-hydroxybenzenemethanol
- [An adrenergic agonist with vasoconstrictive activity. Etilefrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to a decrease in venous pooling and increase in blood pressure. This agent may also stimulate beta-1 adrenergic receptors, leading to positive chronotropic and inotropic effects. ( NCI )] (UMLS (NCI) C0015116) =Organic Chemical; Pharmacologic Substance ;
|
- 6113. AORTIC ANEURYSM NOS
- [ ] (UMLS (ICD9CM) C0340629) =Disease or Syndrome ;
| - 6163. APHAKIA
- [Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION. ( MSH )] (UMLS (ICD9CM) C0003534) =Anatomical Abnormality ;
|
- 6114. Aortic aneurysm of unspecified site, ruptured
- [ ] (UMLS (ICD9CM) C0741160) RUPT AORTIC ANEURYSM NOS;
Ruptured Aortic Aneurysm;
=Disease or Syndrome ;
| - 6164. Aphakia and other disorders of lens
- [ ] (UMLS (ICD9CM) C0155371) =Disease or Syndrome ;
|
- 6115. Aortic Arch
- (UMLS (NCI) C0003489) =Body Part, Organ, or Organ Component
| - 6165. aphasia
- [cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form; caused by diseases which affect the language areas of the dominant hemisphere; general categories include receptive, expressive, and mixed forms of aphasia. ( CSP )] (UMLS (CSP) C0003537) =Mental or Behavioral Dysfunction ;
|
- 6116. Aortic Arch Syndrome
- [Conditions resulting from abnormalities in the arteries branching from the ASCENDING AORTA, the curved portion of the aorta. These syndromes are results of occlusion or abnormal blood flow to the head-neck or arm region leading to neurological defects and weakness in an arm. These syndromes are associated with vascular malformations; ATHEROSCLEROSIS; TRAUMA; and blood clots. ( MSH )] (UMLS (NCI) C0003490) =Disease or Syndrome
| - 6166. Aphasia as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489985) =Mental or Behavioral Dysfunction ;
|
- 6117. AORTIC ATHEROSCLEROSIS
- [ ] (UMLS (ICD9CM) C0155733) =Disease or Syndrome ;
| - 6167. aphemia
- [ ] (UMLS (CSP) C0597893) =Mental or Behavioral Dysfunction
|
- 6118. AORTIC ATRESIA/STENOSIS
- (UMLS (ICD9CM) C0345010) =Congenital Abnormality; Disease or Syndrome
| - 6168. apheresis
- [(fer-E-sis) A procedure in which blood is collected, part of the blood such as platelets or white blood cells is taken out, and the rest of the blood is returned to the donor. ( NCI )] (UMLS (NCI) C0005791) =Therapeutic or Preventive Procedure ;
|
- 6119. aortic balloon pump
- [counterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole; as the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure; the result is a decrease in left ventricular work and increased myocardial and peripheral perfusion. ( CSP )] (UMLS (CSP) C0178483) =Medical Device =auxiliary heart prosthesis;
| - 6169. aphidicolin
- [terpenoid compound from the fungus Cephalosporium amphidicola which inhibits eukaryotic, alpha-type DNA polymerases; used in tissue culture to synchronize cell division; derivatives are potential antineoplastic and antiAIDS agents. ( CSP )] (UMLS (CSP) C0085171) =Organic Chemical; Pharmacologic Substance =antimetabolite;
|
- 6120. aortic body
- [Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the coronary arteries. The aortic bodies sense PH; CARBON DIOXIDE; and oxygen concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen (which are sometimes also called aortic bodies). ( MSH )] (UMLS (CSP) C1510461) glomus aorticum;
=Body Part, Organ, or Organ Component ;
| - 6170. APHONIA
- [Complete loss of phonation due to organic disease of the larynx or to nonorganic (i.e., psychogenic) causes. ( MSH )] (UMLS (ICD9CM) C0003564) =Sign or Symptom ;
|
- 6121. Aortic Body Neoplasm
- [A benign or malignant extra-adrenal parasympathetic paraganglioma that arises from paraganglia adjacent to the base of the heart and great vessels. ( NCI )] (UMLS (NCI) C0334417) =Neoplastic Process
| - 6171. aphthous stomatitis
- [recurrent disease of the oral mucosa of unknown etiology, characterized by small white ulcerative lesions lasting 7 to 14 days. ( CSP )] (UMLS (CSP) C0038363) =Disease or Syndrome ;
=skin ulcer;
stomatitis |
- 6122. Aortic Dissection
- (UMLS (NCI) C0340643) =Disease or Syndrome; Anatomical Abnormality
| - 6172. Aphthovirus
- [A genus of the family PICORNAVIRIDAE infecting mainly cloven-hoofed animals. They cause vesicular lesions and upper respiratory tract infections. FOOT AND MOUTH DISEASE VIRUS is the type species. ( MSH )] (UMLS (CSP) C0016515) =Virus ;
|
- 6123. Aortic Injury
- (UMLS (NCI) C0854391) =Injury or Poisoning
| - 6173. API 20 Strep
- [Identification, API 20 Strep ( HL7V3.0 )] (UMLS (HL7) C1553129) =Laboratory Procedure =ObservationMethod;
|
- 6124. Aortic Insufficiency
- [backflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve. ( CSP )] (UMLS (NCI) C0003504) =Disease or Syndrome
| - 6174. API 20A
- [Identification, API 20A ( HL7V3.0 )] (UMLS (HL7) C1553130) =Laboratory Procedure =ObservationMethod;
|
- 6125. Aortic Malignant Neoplasm
- (UMLS (NCI) C1334560) Aortic Malignant Tumor;
Malignant Aortic Neoplasm;
Malignant Neoplasm of Aorta;
Malignant Neoplasm of the Aorta;
Malignant Tumor of Aorta;
Malignant Tumor of the Aorta;
=Neoplastic Process | - 6175. API 20C AUX
- [Identification, API 20C AUX ( HL7V3.0 )] (UMLS (HL7) C1553131) =Laboratory Procedure =ObservationMethod;
|
- 6126. Aortic Rim
- (UMLS (HL7) C1549093) =Body Part, Organ, or Organ Component =Body Part;
| - 6176. API 20E
- [Identification, API 20E ( HL7V3.0 )] (UMLS (HL7) C1553132) =Laboratory Procedure =ObservationMethod;
|
- 6127. Aortic Segment
- (UMLS (NCI) C0506947) =Body Part, Organ, or Organ Component
| - 6177. API 20NE
- [Identification, API 20NE ( HL7V3.0 )] (UMLS (HL7) C1553133) =Laboratory Procedure =ObservationMethod;
|
- 6128. Aortic Stenosis
- [constriction in the opening of the aortic valve or of the supravalvular or subvalvular regions. ( CSP )] (UMLS (NCI) C0003507) =Disease or Syndrome
| - 6178. API 50 CH
- [Identification, API 50 CH ( HL7V3.0 )] (UMLS (HL7) C1553134) =Laboratory Procedure =ObservationMethod;
|
- 6129. aortic valve
- [valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. ( CSP )] (UMLS (CSP) C0003501) =Body Part, Organ, or Organ Component
| - 6179. API An-IDENT
- [Identification, API An-IDENT ( HL7V3.0 )] (UMLS (HL7) C1553135) =Laboratory Procedure =ObservationMethod;
|
- 6130. AORTIC VALVE DISORDER
- [condition in which there is a deviation from or interruption of the normal structure or function of the valve between the left ventricle and the ascending aorta. ( CSP )] (UMLS (ICD9CM) C1260873) Aortic valve disorders;
Diseases of aortic valve =Disease or Syndrome ;
=Heart Valve Diseases;
=Aortic Stenosis;
| - 6180. API Coryne
- [Identification, API Coryne ( HL7V3.0 )] (UMLS (HL7) C1553136) =Laboratory Procedure =ObservationMethod;
|
- 6131. Aortic Valve Replacement
- [Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with bioprosthetic, homograft or autograft valve. ( NCI )] (UMLS (NCI) C0003506) =Therapeutic or Preventive Procedure
| - 6181. API Rapid 20E
- [Identification, API Rapid 20E ( HL7V3.0 )] (UMLS (HL7) C1553137) =Laboratory Procedure =ObservationMethod;
|
- 6132. AORTOCORONARY BYPASS
- (UMLS (ICD9CM) C0032811) =Finding
| - 6182. API Staph
- [Identification, API Staph ( HL7V3.0 )] (UMLS (HL7) C1553138) =Laboratory Procedure =ObservationMethod;
|
- 6133. Aortocoronary bypass for heart revascularization, not otherwise specified
- [surgical procedure creating a bridge between the ascending aorta and one or more of the three major coronary arteries, distal to an obstructive lesion, using autologous tissue transplanted from the saphenous vein. ( CSP )] (UMLS (ICD9CM) C0010055) =Therapeutic or Preventive Procedure ;
=heart revascularization;
| - 6183. API ZYM
- [Identification, API ZYM ( HL7V3.0 )] (UMLS (HL7) C1553139) =Laboratory Procedure =ObservationMethod;
|
- 6134. Aortography
- [Radiographic visualization of the aorta and its branches by injection of contrast media, using percutaneous puncture or catheterization procedures. ( MSH )] (UMLS (ICD9CM) C0003515) =Diagnostic Procedure
| - 6184. API1
- [This gene is a potent inhibitor of apoptosis and plays an important role in apoptotic signal transduction. ( NCI )] (UMLS (NCI) C1332414) Baculoviral IAP Repeat-Containing 2 Gene;
BIRC2;
BIRC2 Gene =Gene or Genome ;
|
- 6135. Aotal
- [ ] (UMLS (CSP) C1113660) =Organic Chemical; Pharmacologic Substance ;
| - 6185. API4
- [an anti-apoptosis protein expressed in lymphoma and cancers of lung, colon, pancreas, prostate and breast; potent inhibitor of some caspases. ( CSP )] (UMLS (NCI) C0664336) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=MAP;
Tumor Antigen |
- 6136. Aotus
- [nocturnal monkey of Central America and South America with large eyes, thick fur, and tiny external ears. ( CSP )] (UMLS (CSP) C1265472) =Mammal =Cebidae;
| - 6186. Apical
- [Relating to or located at the tip (an apex). ( NCI )] (UMLS (NCI) C0205111) =Spatial Concept
|
- 6137. AP
- [A pre-filled non-injectable pipette, syringe or tube. ( NCI )] (UMLS (NCI) C0179108) =Medical Device =Administration Device;
Unclassified Ingredients =APPLICATOR POINTED;
| - 6187. apical membrane
- [cell membrane found on the surface of vertebrate epithelial cells which faces the external lumen and may be involved in transport of substances across the cell. ( CSP )] (UMLS (CSP) C0596119) =Cell Component ;
=cell membrane;
|
- 6138. AP
- (UMLS (NCI) C0279212) =Therapeutic or Preventive Procedure
| - 6188. Apical Myocardial Infarction
- (UMLS (NCI) C1168331) =Disease or Syndrome
|
- 6139. AP Endonuclease Class I
- [APEX Nuclease, encoded by the APE1 gene, is a ubiquitous monomeric apurinic/apyrimidinic DNA repair endonuclease (AP/EXOA family) with 3-prime-, 5-prime-exonuclease, DNA 3-prime repair diesterase, and DNA 3-prime-phosphatase activities. The constitutive gene contains five exons spanning 2.64 kb; the first exon is untranslated. The 0.5 kb upstream DNA contains only a possible CCAAT box and no other regulatory sites or a TATA box. A potent activator of p53 protein, APE1 may protect against cell lethality and suppress mutations produced by spontaneous hydrolysis, by chemicals and radiation, or by DNA glycosylases that remove abnormal bases from DNA. Abasic sites that can block DNA replication and cause mutations must be corrected to restore genetic integrity. A repressor of the PTH gene, APE binds to promoter negative Ca(2+)-response elements, which are also present in the APE1 gene. ( NCI )] (UMLS (NCI) C0140145) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 6189. Apicectomy
- [The surgery involving excision of the apex of the petrous portion of the temporal bone. ( NCI )] (UMLS (NCI) C0003571) =Therapeutic or Preventive Procedure ;
|
- 6140. AP-2 Family Protein
- [Activator Protein 2. Originally identified as a cellular transcription factor that binds the enhancer region of SV40. It is encoded by a family of related genes, AP-2 alpha, AP-2 beta, and AP-2 gamma. AP-2 is developmentally regulated and inducible by RET. ( NCI )] (UMLS (NCI) C1332097) AP-2 Family Transcription Factor;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 6190. Apicoectomy and root canal therapy
- [ ] (UMLS (ICD9CM) C0176403) =Therapeutic or Preventive Procedure
|
- 6141. Ap3A Hydrolase
- [FHIT protein is a 147-amino acid AP3A hydrolase. The FHIT preferred substrate, AP3A (diadenosine 5-prime,5-triple prime-P(1),P(3)-triphosphate), and AP4A have been proposed to have various intracellular functions, including regulation of DNA replication and signaling stress responses. (from OMIM) ( NCI )] (UMLS (NCI) C1173495) AP3Aase;
bis(5'-adenosyl)-triphosphatase;
Diadenosine 5',5'''-P1,P3-triphosphate Hydrolase;
Dinucleosidetriphosphatase;
FHIT;
FHIT Protein =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 6191. Apicomplexa
- [phylum of protozoa characterized by the presence of complex apical organelles generally consisting of a conoid that aids in penetrating host cells, rhoptries that possibly secrete a proteolytic enzyme, and subpellicular microtubules that may be related to motility. ( CSP )] (UMLS (CSP) C0085316) =Invertebrate ;
=protozoa;
=Babesia;
Coccidia;
Plasmodium;
|
- 6142. Apache
- (UMLS (NCI) C0337855) =Population Group =American Indian;
=Chiricahua;
Fort Sill Apache;
Jicarilla Apache;
Lipan Apache;
Mescalero Apache;
Oklahoma Apache;
Payson Apache;
San Carlos Apache;
White Mountain Apache | - 6192. APL unit
- [biologic activity of anticardiolipin IgA ( HL7V3.0 )] (UMLS (HL7) C1552996) =Quantitative Concept =UnitOfMeasureAtomInsens;
UnitOfMeasureAtomSens |
- 6143. Apache Tribe of Oklahoma
- (UMLS (HL7) C1554225) =Population Group =NativeEntityContiguous;
| - 6193. Aplastic anemia and other bone marrow failure syndromes
- [ ] (UMLS (ICD9CM) C1719323) =Disease or Syndrome
|
- 6144. Apachean
- (UMLS (HL7) C1698047) =Language ;
=Athapaskan;
=Kiowa Apache;
EasternApachean;
WesternApachean;
| - 6194. Aplastic Anemia due to Infection
- (UMLS (NCI) C0271912) =Disease or Syndrome
|
- 6145. APAF1
- [The APF1 protein functions to activate caspase 9 in the cytochrome c/dATP-dependent apoptotic pathway. (from RefSeq Summary) ( NCI )] (UMLS (NCI) C0664613) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 6195. Aplastic Anemia due to Radiation
- (UMLS (NCI) C0472734) =Disease or Syndrome
|
- 6146. APAF1
- [This gene is involved in pro-apoptotic regulation through caspase interaction. ( NCI )] (UMLS (NCI) C1332098) APAF1 Gene;
Apoptotic Protease Activating Factor 1 Gene =Gene or Genome ;
| - 6196. APLASTIC ANEMIAS NEC
- [ ] (UMLS (ICD9CM) C1955746) Other specified aplastic anemias;
=Disease or Syndrome |
- 6147. APAF3
- [Caspase-9 is encoded by the CASP9 Gene. Caspase-9 is the most upstream member of the apoptotic protease cascade that is triggered by cytochrome c and dATP. Caspase-9 and APAF1 bind to each other in the presence of cytochrome c and dATP, an event that leads to caspase-9 activation. Activation of procaspase-9 by APAF1 requires proteolytic cleavage to generate the mature caspase molecule. Activated caspase-9 in turn cleaves and activates caspase-3. APAF1-mediated processing of procaspase-9 occurs at asp315 by an intrinsic autocatalytic activity of procaspase-9 itself. APAF1 can form oligomers and may facilitate procaspase-9 autoactivation by oligomerizing its precursor molecules. Once activated, caspase-9 can initiate a biochemical cascade involving the downstream executioners caspase-3, -6, and -7. Alternative splicing of this gene results in two transcript variants which encode different isoforms. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0910167) APAF-3;
Apoptotic Protease Activating Factor 3;
Apoptotic Protease MCH-6;
CASP9;
CASP-9;
CASP9 Protein;
Caspase 9, Apoptosis-Related Cysteine Protease;
Caspase-9;
EC 3.4.22.-;
ICE-LAP6;
ICE-Like Apoptotic Protease 6;
MCH6 =Amino Acid, Peptide, or Protein; Enzyme | - 6197. APLD
- [An anticancer drug obtained from a marine animal. ( NCI )] (UMLS (NCI) C0388638) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 6148. Apartment
- [A room or suite of rooms designed as a residence and generally located in a building occupied by more than one household used as an element of an address. ( NCI )] (UMLS (NCI) C0457933) =Manufactured Object
| - 6198. Aplysia
- [genus of motile gastropods with a poorly developed or missing shell; used in neurobiology studies because it possesses a simple nervous system with large, individually identifiable neurons. ( CSP )] (UMLS (CSP) C0003577) =Invertebrate ;
|
- 6149. apatite
- [family of minerals composed of mutilples of Ca5-(PO4)6-OH; one of the 2 major minerals of bones and teeth, the other being calcium carbonate. ( CSP )] (UMLS (CSP) C0003522) =Inorganic Chemical ;
| - 6199. Aplysia Ras-Related Homolog 12
- [RHO A GTP-binding protein is involved in regulating signal transduction pathways that control assembly of focal adhesions and actin stress fibers. Rho regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Active Rho signals to its downstream effector ROCK1, which phosphorylates and activates LIM kinase. LIM kinase, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. (from OMIM 165390 and NCI) ( NCI )] (UMLS (NCI) C0084340) =Amino Acid, Peptide, or Protein; Enzyme
|
- 6150. APC
- [Ectopic impulses originating in the atria. ( NCI )] (UMLS (NCI) C0033036) =Disease or Syndrome =Cardiac Complexes, Premature;
| - 6200. Aplysia RAS-Related Homolog 9
- [RHO C protein is a product of the ARHC gene that regulates remodeling of the actin cytoskeleton during cell morphogenesis and motility. Rho C enhances metastasis when over expressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho C indicates that Rho C is important in tumor cell invasion. (from OMIM 165380 and NCI) ( NCI )] (UMLS (NCI) C0084342) =Amino Acid, Peptide, or Protein; Enzyme
|
home 
Armenian-English 
top